冠状动脉旁路移植市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

冠状动脉搭桥移植市场按技术(非体外循环 CABG、非体外循环 CABG 等)、产品和服务、最终用户和地理划分

冠状动脉旁路移植市场快照

coronary artery bypass grafting market size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >7.8 %
coronary artery bypass grafting market key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,研究的冠状动脉旁路移植市场预计将以近 7.8% 的复合年增长率增长。推动市场增长的主要因素是各种冠心病的全球流行、有利的报销计划以及老年人口的增加。例如,根据 2018 年发布的《全球健康与健康报告》,美国近 40% 的成年人被诊断出患有心血管疾病,这直接导致对冠状动脉搭桥手术和更好的心血管设备的需求增加有效的治疗方法在整个预测期内推动了市场的增长。

报告范围

冠状动脉旁路移植术 (CABG) 是一种用于冠状动脉疾病 (CAD) 患者的手术治疗,其中创建了一条可供血液流向心脏的替代通道。在手术过程中绕过三或四支冠状动脉是很常见的。导致 CAD 的各种因素包括焦虑、办公桌的生活方式、垃圾食品的大量消耗和压力。

By Technology
Off-pump CABG
On-pump CABG
Others
By Products and Services
Grafts
Retractors
Services
Others
By End-Users
Hospitals
Cardiology Clinics
Other
Geography
North America
United states
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

体外循环 CABG 技术板块有望在冠状动脉旁路移植市场占据最大市场份额

  • 在预测期内,泵上 CABG 技术预计将见证冠状动脉旁路移植市场的最大市场份额。这种主导地位是由于在 CABG 程序中增加使用各种设备,如氧合器、稳定器和心肺机,推动了市场的增长。另一方面,由于该技术的快速进步提高了安全性、效率、最大限度地减少了手术中出血的机会以及降低了中风和受伤的风险,预计非体外循环 CABG 部分在预测期内将以最快的复合年增长率增长到心肌。此外,
  • 基于最终用户,由于患有慢性病的患者的高度偏好以及先进基础设施的可用性,由于医院中存在大量新病例,预计医院将在市场中占据最大份额预计这将在预测期内推动市场增长。
coronary artery bypass grafting market growth

北美在市场上占主导地位,预计在预测期内也会如此。

预计北美将在整个预测期内主导整个 CABG 市场。导致增长的主要因素是全球多种心血管疾病的患病率急剧上升,如 CAD、中风和心房颤动,这是由于糖尿病和肥胖症等慢性疾病的增加需要 CABG 手术,因此对外科手术的需求增加移植物和装置。例如,根据美国医学协会杂志 2018 年的报告,美国约有 9330 万 20 岁以上的成年人肥胖,这是导致冠心病的主要原因,直接推动了该地区市场的增长收入的突出份额推动了全球 CABG 市场。

coronary artery bypass grafting market analysis

竞争格局

冠状动脉旁路移植市场竞争中等,由几个主要参与者组成。很少有主要参与者正在开发新颖的产品和技术以与现有产品竞争,而其他主要参与者正在收购市场上的其他公司并与之合作。例如,2018 年 2 月,Aesculap, Inc. 完成了对 Dextera Surgical Inc. 的资产收购。通过此次收购,Aesculap 扩大了其产品组合,增加了创新的 MicroCutter 5/80 吻合器、PAS-Port 近端吻合系统和用于 CABG 手术的创新设备其现有的医疗设备为公司在心胸外科市场的增长做出了贡献,预计这将推动全球 CABG 市场在整个预测期内的增长。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Global Prevalence of Cardiac Disorders such as Strokes and Coronary Heart Diseases

      2. 4.2.2 Availability of Technologically Advanced Products and Reimbursement Policies

    3. 4.3 Market Restraints

      1. 4.3.1 Adoption of Minimally Invasive Procedures like Percutaneous Coronary Interventions.

      2. 4.3.2 Highly Expensive Treatments and Lack of Advanced Healthcare Infrastructure.

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technology

      1. 5.1.1 Off-pump CABG

      2. 5.1.2 On-pump CABG

      3. 5.1.3 Others

    2. 5.2 By Products and Services

      1. 5.2.1 Grafts

      2. 5.2.2 Retractors

      3. 5.2.3 Services

      4. 5.2.4 Others

    3. 5.3 By End-Users

      1. 5.3.1 Hospitals

      2. 5.3.2 Cardiology Clinics

      3. 5.3.3 Other

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United states

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Terumo Medical Corporation

      2. 6.1.2 Getinge AB

      3. 6.1.3 Genesee Biomedical Inc

      4. 6.1.4 Medtronic plc

      5. 6.1.5 Karl Storz SE & Co KG

      6. 6.1.6 Scanlan International Inc

      7. 6.1.7 Neograft Inc

      8. 6.1.8 Vitalitec International Inc

      9. 6.1.9 Edwards Lifesciences

      10. 6.1.10 Stryker Inc

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Coronary Artery Bypass Grafting Market market is studied from 2018 - 2026.

The Coronary Artery Bypass Grafting Market is growing at a CAGR of >7.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Medtronic Plc, Getinge AB, Terumo Medical Corporation, Genesee Biomedical Inc, Karl Storz SE & Co KG are the major companies operating in Coronary Artery Bypass Grafting Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!